Saxagliptin in Combination With Dapagliflozin - Effects on Islet Cell Function

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to evaluate alpha- and beta-cell function during combination treatment with saxagliptin in addition to dapagliflozin and metformin compared to placebo in addition to dapagliflozin and metformin in subjects with T2DM on stable metformin background therapy.
Epistemonikos ID: 882dfd2b61267fbe41a5774a28f1dc791676278e
First added on: May 12, 2024